Abiopharma

(82% Neutral) QUEST DIAGNOSTICS INCORPORATED (DGX) Announces Business Combination

📋 MATTHEW RABINOWITZ (Director) plans to sell 200K shares of NATERA, INC. (at $196.61 each, total $39.3M) Filed: Mar 12, 2026 | ID: 002547

Director Turley James S 🟢 acquired 94.5K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003689

📋 ROGERIO VIVALDI COELHO (Director) plans to sell 5K shares of Crinetics Pharmaceuticals, Inc. (at $36.98 each, total $185K) Filed: Mar 12, 2026 | ID: 002543

Director KINDLER JEFFREY B 🟢 acquired 96.3K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003688

📋 STEPHEN MAYO (Director) plans to sell 7K shares of SAREPTA THERAPEUTICS, INC. (at $17.02 each, total $123K) Filed: Mar 12, 2026 | ID: 002538

Director Hassan Fred 🟢 acquired 94.6K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003687

LANGE LOUIS G 🔴 sold 44.6K shares of NewAmsterdam Pharma Co N.V. (NAMS) at $31.23 ($1.4M) Transaction Date: Mar 11, 2026 | Filing ID: 104239

Director Gupta Vinita D 🟢 acquired 94.6K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003685

Hickey Benjamin 🟢 acquired 28.6K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000006